Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation

Published:2011-03-28 Issue:2 Volume:47 Page:251-257
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Peric Z,Cahu X,Chevallier P,Brissot E,Malard F,Guillaume T,Delaunay J,Ayari S,Dubruille V,Le Gouill S,Mahé B,Gastinne T,Blin N,Saulquin B,Harousseau J-L,Moreau P,Coste-Burel M,Imbert-Marcille B-M,Mohty M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201164.pdf

Reference31 articles.

1. Kelly SS, Parmar S, De Lima M, Robinson S, Shpall E . Overcoming the barriers to umbilical cord blood transplantation. Cytotherapy 2010; 12: 121–130.

2. Brunstein CG, Wagner JE . Umbilical cord blood transplantation and banking. Annu Rev Med 2006; 57: 403–417.

3. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.

4. Grewal SS, Barker JN, Davies SM, Wagner JE . Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233–4244.

5. Mohty M, Rocha V, Chevallier P, Harousseau JL, Nagler A . Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later. Curr Opin Oncol 2009; 21 (Suppl 1): S1.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral monitoring in immunocompromised hosts;Molecular Medical Microbiology;2024

2. Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.;Blood Advances;2022-11-09

3. Complications after Cord Blood Transplantation: current and future perspectives;Japanese Journal of Transplantation and Cellular Therapy;2022

4. Clinical Characteristics of Posttransplant Lymphoproliferative Disorder After Cord Blood Transplantation Without Antithymocyte Globulin;Clinical Lymphoma Myeloma and Leukemia;2021-12

5. Risk factors for post‐transplant Epstein‐Barr virus events in pediatric recipients of hematopoietic stem cell transplants;Pediatric Transplantation;2021-06-02